Kala Pharmaceuticals Inc

NASDAQ:KALA   3:59:50 PM EDT
1.72
-0.10 (-5.50%)
Earnings Announcements

Kala Pharmaceuticals Reports Third Quarter 2021 Financial Results

Published: 11/15/2021 14:07 GMT
Kala Pharmaceuticals Inc (KALA) - Kala Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Corporate Update.
Q3 Loss per Share $0.43.
Q3 Revenue $3.1 Million.
Revenue is expected to be $3.49 Million
Adjusted EPS is expected to be -$0.39

Next Quarter Revenue Guidance is expected to be $4.53 Million
Next Quarter EPS Guidance is expected to be -$0.39

More details on our Analysts Page.